Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab, Immunoadsorption, and Dexamethasone in Pemphigus
NCT00656656Phase 2Completed
- Sponsor
- University of Lübeck
- Start
- Jan 2008
- Primary completion
- Jul 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of rituximab in pemphigus, sponsored by University of Lübeck. Primary endpoint: Short- and Long-term Remission of Pemphigus at 43 months. Started Jan 2008; status: completed.
02
Drugs
rituximab
03
Conditions
pemphigus
Beyond the preview
Go deeper on NCT00656656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00656656.